Novo Nordisk reported DKK114.94B in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Bausch Health Companies USD 2.26B 72M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novo Nordisk DKK 114.94B 8.68B Jun/2026
Novo Nordisk DKK 17.56B 82.7B Jun/2026
Pacira USD 132.42M 6.78M Jun/2026
Sanofi EUR 492M 10M Jun/2026
Supernus Pharmaceuticals USD 211.66M 29.47M Jun/2026